Noxopharm Health Care
Biotech Cancer Healthcare

$0.043 0.002 (4.88%)

High $0.05	Low $0.04	Trades 61	Turnover $61,445	Volume 1,415,719
30 June 2023 at 4:10pm

Market Cap (5-Aug) $27,036,940 (896th)	Close (30-Jun) $0.043 0 (0%)	Volume (30-Jun) 1,415,719	Shortsold (28-Jul) 9,800 (0.00%) (608th)
52w High $0.135	52w Low $0.051	P/E -	EPS -0.02

Short Interest

ASIC data, 28 Jul 2026

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

608th

of 708 shorted ASX stocks

Peak Short

2.88%

Sep 2016

Days to Cover

0.1

at 50d avg vol

View full short position history →

	Subject
	NOX NOX Ann: Noxopharm Corporate Presentation
	1 (current) 2 3
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Application for quotation of securities - NOX
	NOX NOX Ann: DARRT-2 Study Update and Clarification
	NOX NOX Ann: The Noxopharm Newsletter June 2021
	NOX NOX Ann: Noxopharm Set to Benefit From Novartis ASCO Data
	NOX NOX Ann: Becoming a substantial holder
	NOX NOX Ann: Change of Director's Interest Notice - FB
	NOX NOX Ann: Change of Director's Interest Notice - BP
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Appendix 3G
	NOX NOX Ann: Noxopharm Extraordinary General Meeting Results
	NOX NOX Ann: New Independent Trial Data Supports Potential of Veyonda
	NOX NOX Ann: Noxopharm to Present to Share Cafe Hidden Gems Webinar
	NOX NOX Ann: NOXCOVID Trial Achieves Full Enrolment
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Veyonda FDA Approved Trial to Commence
	NOX NOX Ann: Securities Trading Policy
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Change of Director's Interest Notice - BP
	NOX NOX Ann: Lapsing of Unlisted Options
	NOX NOX Ann: Publications Positive Review of Veyonda in Chemotherapy
	NOX NOX Ann: Notice of General Meeting/Proxy Form
	NOX NOX Ann: March Quarterly Activities Report and Appendix 4C
	NOX NOX Ann: Veyonda Showing Potential to Prevent Cytokine Storm
	NOX NOX Ann: Pause in Trading
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Veyonda Patent Lodged for Major Septic Shock Opportunity
	NOX NOX Ann: Corporate Presentation for Switzer Virtual Investor Day
	NOX NOX Ann: Noxopharm IONIC Immuno-Oncology Trial Commences
	NOX NOX Ann: ASX Small-Mid Cap Conference Corporate Presentation
	NOX NOX Ann: NOXCOVID Trial Advances to Final Stage
	NOX NOX Ann: Noxopharm Presents to H.C. Wainwright Global Conference
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Noxopharm Receives A$4.59M Federal Gov R&D Tax Rebate
	NOX NOX Ann: Proposed issue of Securities - NOX
	NOX NOX Ann: Lapsing of Unlisted Options and Shortfall Shares
	NOX NOX Ann: Change of Director's Interest Notice - PM
	NOX NOX Ann: Change in substantial holding
	NOX NOX Ann: Change of Director's Interest Notice - GK
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Company Announcement Regarding Appendix 3Y Disclosures
	NOX NOX Ann: Change in substantial holding
	NOX NOX Ann: Change of Director's Interest Notice - GK

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
05-Aug	$0.09	53,434	+0.01 (11.39%)
04-Aug	$0.08	128	0.00 (0.00%)
03-Aug	$0.08	82,308	0.00 (3.66%)
31-Jul	$0.08	22,449	0.00 (0.00%)
30-Jul	$0.08	191,005	-0.01 (10.87%)
29-Jul	$0.09	99,039	-0.01 (8.00%)
28-Jul	$0.10	156,577	+0.02 (21.95%)
27-Jul	$0.08	10,306	-0.01 (7.87%)
24-Jul	$0.09	0	0.00 (0.00%)
23-Jul	$0.09	11,397	+0.00 (3.49%)
22-Jul	$0.09	77,446	+0.00 (4.88%)
21-Jul	$0.08	20,529	0.00 (0.00%)
20-Jul	$0.08	0	0.00 (0.00%)
17-Jul	$0.08	22,699	-0.01 (10.87%)
18-Sep	$0.09	85,328	-0.01 (6.12%)
4 up, 6 down, and 5 flat days

Noxopharm Health Care
Biotech Cancer Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Noxopharm Health Care Biotech Cancer Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Noxopharm Health Care
Biotech Cancer Healthcare